Psychiatry , 2007 , 46 (4), 435-436
The Bioavailability Challenge: Why Milligrams Aren't Everything When you see "1500 mg" on a supplement label, it is easy to assume your body is receiving exactly that amount
Some GLP-1 medications are FDA-approved to treat type 2 diabetes and used off-label for weight loss, while others are approved specifically to treat obesity
Low-grade endometrial stromal sarcoma with intravenous and intracardiac extension: a multidisciplinary approach
Studies in animal models showed that dual GIP/GLP-1 activation achieved more weight loss than GLP-1 activation by itself
The region's commanding position is underpinned by the highest per-capita penetration of GLP-1 receptor agonist prescriptions in the world, driven by the United States' exceptionally high prevalence of type 2 diabetes (affecting approximately 37.3 million people) and obesity (affecting approximately 42.4% of the adult population)